Literature DB >> 17053390

A unique presentation of appendicitis: F-18 FDG PET/CT.

Stacey G Koff1, Joseph R Sterbis, Jonathan M Davison, Jaime L Montilla-Soler.   

Abstract

A 27-year-old white man was diagnosed with a testicular, metastatic germ cell tumor. The patient was evaluated with F-18 fluorodeoxyglucose positron emission tomography and coregistered computed tomography (FDG PET/CT) as well as a contrast-enhanced CT (CECT) of the abdomen and pelvis. Serologic tests were performed. At laparoscopic appendectomy, findings were consistent with acute suppurative appendicitis. This case exemplifies the relevance of incidental findings detected on FDG PET/CT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17053390     DOI: 10.1097/01.rlu.0000242723.61455.a8

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  5 in total

1.  Normal patterns of 18F-FDG appendiceal uptake in children.

Authors:  Hamilton E Reavey; Adina L Alazraki; Stephen F Simoneaux
Journal:  Pediatr Radiol       Date:  2013-11-28

Review 2.  Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography.

Authors:  Rakesh Kumar; Sandip Basu; Drew Torigian; Vivek Anand; Hongming Zhuang; Abass Alavi
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

3.  Acute appendicitis from metastatic small cell lung cancer.

Authors:  Radhika Sundararajan; Adam B Landman
Journal:  West J Emerg Med       Date:  2012-02

Review 4.  The impact of infection and inflammation in oncologic 18F-FDG PET/CT imaging.

Authors:  W Tania Rahman; Daniel J Wale; Benjamin L Viglianti; Danyelle M Townsend; Matthew S Manganaro; Milton D Gross; Ka Kit Wong; Domenico Rubello
Journal:  Biomed Pharmacother       Date:  2019-07-01       Impact factor: 6.529

Review 5.  Acute Findings on FDG PET/CT: Key Imaging Features and How to Differentiate Them from Malignancy.

Authors:  Yan Li; Spencer Behr
Journal:  Curr Radiol Rep       Date:  2020-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.